Brief: Nippon Kayaku initiates phase II clinical trials on NK105 for treatment of breast cancer

Nippon Kayaku Co

21/02/2018 03:32

Feb 21 (Reuters) - Nippon Kayaku Co Ltd  4272.T   
     
    * Says it initiated phase II clinical trials on NK105 for 
treatment of breast cancer  
 
     
    Source text in Japanese:https://goo.gl/nKdFZC 
    Further company coverage: 4272.T  
 
 (Beijing Headline News) 
 ((Beijing.HeadlineNews@thomsonreuters.com; +8601082555111; 
Reuters Messaging: Pingping.Li1@thomsonreuters.com@reuters.net))